India's equity benchmarks ended largely flat on Friday, as profit booking in consumer stocks and concerns over US tariffs offset broader gains, while sustained foreign institutional investor outflows weighed on sentiment.
The market saw a volatile session, with advances in some sectors balanced by declines in information technology shares, reflecting caution among investors over economic fallout from ongoing global trade tensions.
The BSE Sensex fell 7.25 points, or 0.01%, to close at 80,710.76, while the NSE Nifty 50 rose 6.70 points, or 0.03%, to settle at 24,741.
Among individual stocks, Eicher Motors (NSE:EICHERMOT, BOM:505200) led the gainers with a rise of over 2%, followed by Mahindra & Mahindra (NSE:M&M, BOM:500520) and Maruti Suzuki India (NSE:MARUTI, BOM:532500).
ITC (NSE:ITC, BOM:500875), HCL Technologies (NSE:HCLTECH, BOM:532281) and Tech Mahindra (NSE:TECHM, BOM:532755) were the top laggards.
On the corporate front, Glenmark Pharmaceuticals (NSE:GLENMARK, BOM:532296) announced the start of a multi-country Phase 3 clinical trial for Envafolimab, a novel subcutaneous PD-L1 inhibitor for patients with resectable stage III non-small cell lung cancer (NSCLC) in neoadjuvant or adjuvant settings, according to a Friday filing.
Separately, Tata Consultancy Services (NSE:TCS, BOM:532540) secured a contract from the Odisha state government to design and implement the integrated financial management system (IFMS) 3.0, aimed at automating public finance workflows.
精彩评论